Boston Commerce — 360° view

Boston Commerce, a company in the Healthcare Service Provider industry, reported revenue of ₹0.06 crore and a net loss of ₹0.01 crore for the December 2025 quarter.

Boston Commerce (BSE: BOSTON) closed at ₹11.18 on 20 Nov 2026, up 66.9% over the past year. Its market capitalisation is ₹8 crore.

Share price
₹11.18 (20 Nov 2026)
Market cap
₹8 Cr (20 Nov 2026)
Revenue
₹0 Cr (December 2025 quarter)
Net profit
₹-0 Cr (December 2025 quarter)
ROCE
-112% (FY26)
ROE
-310% (FY26)
Book value
₹-1.81 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹12.30 / ₹4.01 (20 Nov 2026)
1-year return
66.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
BSE: BOSTON

Incorporated in 1995, Boston Bio Systems Ltd is in the business of trading in goods e.g. Medical equipment, testing kits, instruments etc.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.